NUTEX HEALTH INCNUTX
ASignal's systematic analysis rates NUTX as Bullish.
Reflects the latest available analysis · analyzed Sep 17, 2026
The case on NUTX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong operating and gross margins (57.75% and 54.51%) indicating pricing power and cost control
- High return on equity (64.56%) reflecting efficient use of shareholder capital
- Low debt-to-equity ratio (0.68x) suggesting manageable leverage
- Current price above 20-day EMA (194.08), confirming short-term uptrend
- MACD histogram positive and expanding, signaling strengthening momentum
- Negative year-over-year revenue growth (-13.60%) indicating top-line contraction
- Low growth score (0.3) and missing earnings growth data (N/A)
- RSI at 66.46, approaching overbought territory, potentially limiting near-term upside
- High beta (2.02x) indicating elevated volatility and market sensitivity
- No Reddit mentions, suggesting limited retail investor interest or visibility
See the full verdict on NUTX
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes NUTX
Most investors never get a second opinion, let alone several. ASignal runs NUTX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.